本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Day One Biopharmaceuticals Inc.

7.48
-0.0300-0.40%
成交量:61.04万
成交额:460.76万
市值:7.66亿
市盈率:-7.97
高:7.71
开:7.59
低:7.42
收:7.51
52周最高:16.76
52周最低:5.64
股本:1.02亿
流通股本:7,876.62万
量比:0.67
换手率:0.77%
股息:- -
股息率:- -
每股收益(TTM):-0.9382
每股收益(LYR):-1.0243
净资产收益率:-24.75%
总资产收益率:-15.19%
市净率:1.66
市盈率(LYR):-7.30

数据加载中...

2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/06/03

重要事件披露

Form 8-K - Current report
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/03/06

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities